Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

The Global Summit on Precision Diagnosis and Treatment of Prostate Cancer is a premier event dedicated to advancing the understanding and treatment of prostate cancer through precision diagnostics and innovative therapies. This summit features a robust agenda that encompasses a variety of sessions focusing on key topics such as screening, clinical evaluation, and management of prostate cancer, including localized and advanced stages. Attendees will have the opportunity to engage with leading experts in the field, who will share insights through presentations, panel discussions, and workshops.

The summit's agenda includes sessions led by distinguished speakers such as Faina Shtern, MD, President and CEO of AdMeTech Foundation, and Peter Albers, MD, Chairman of the Department of Urology at Heinrich-Heine-University Düsseldorf. These sessions will cover topics from the evaluation of men with clinical suspicion of prostate cancer to the emerging role of image-targeted, minimally invasive treatments.

Noteworthy discussions will address advancements in liquid diagnostics and imaging tools, as well as the integration of artificial intelligence and machine learning in the diagnostic process. In addition to the scientific presentations, the event will facilitate networking opportunities among healthcare professionals, researchers, and industry leaders, fostering collaboration and innovation in prostate cancer care.

The summit aims to highlight the importance of risk-stratified screening and early detection, with significant contributions from experts like Sigrid Carlsson, MD, PhD, MPH, and Monique Roobol, PhD, who will discuss ongoing trials and initiatives in prostate cancer screening. This is an essential gathering for those involved in urology and oncology, providing a platform for sharing the latest research findings and clinical practices in the field of prostate cancer diagnosis and treatment.